Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ACR, Aetna, Atlanta, atorvastatin, attenuated, Australian, batch, Bertrand, BID, BMS, Branch, budget, cardiac, Catalyst, Citibank, conclusion, concomitant, Connecticut, Connolly, cough, cycle, daclatasvir, death, domain, exacerbation, experimentally, fostering, French, Greece, hearing, indefinitely, irrevocable, Italy, landscape, Lehman, Leonard, lessor, lift, Loi, methylprednisone, MF, midazolam, modest, motion, nasal, Nashville, notional, NV, OLYSIO, oncology, onset, organizational, Owen, pancytopenia, PDUFA, Phoenix, pneumonia, Portugal, pressure, Psychology, reclassified, regular, reply, Republic, retroactively, Robert, SAP, Save, Scotland, screening, Seventeen, shedding, slightly, sofosbuvir, SOVALDI, stable, steeply, Stern, subgroup, subset, Suffolk, tenured, TNF, traditional, tumor, twofold, UBS, upgrading, User, variation, volunteered, washout, waste, Wood, XIR, Zealand
Removed:
accommodate, accrue, adult, affiliate, amortize, analyze, Architecture, Astra, banker, Banking, begun, bifurcation, Christiana, Citigroup, commencing, constraining, customary, Darmstadt, DC, dedication, deduction, depreciated, Dickinson, distinct, EMA, EMD, enzyme, expiring, Farleigh, FASB, Fenner, Fort, fundamental, gating, governed, grow, imposed, inclusion, Incyte, indenture, influence, inhibiting, initiate, issuable, KGaA, launched, lesser, Lynch, match, MEPC, Merrill, nausea, nominal, omission, page, picture, Pierce, predominantly, premium, privately, proceeding, realizability, Realty, recurrent, reform, Registry, Rent, representation, rest, revolving, secure, situated, Sloan, sort, suggested, supplemented, trafficking, transplant, Trust, trustee, unpaid, untrue, vendor, warranty, Wellcome, women, yielded
Filing tables
Filing exhibits
Related press release
VRTX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements (Form S-3 No. 333-186993 and Form S-8 Nos. 333-65666, 333-134482, 333-150945, 333-150946, 333-160442, 333-166803, 333-184784, 333-184787 and 333-188737) of Vertex Pharmaceuticals Incorporated of our reports dated February 11, 2014, with respect to the consolidated financial statements of Vertex Pharmaceuticals Incorporated and the effectiveness of internal control over financial reporting of Vertex Pharmaceuticals Incorporated, included in this Annual Report (Form 10-K) for the year ended December 31, 2013.
/s/ Ernst & Young LLP |
Boston, Massachusetts
February 11, 2014